At meeting held on 08 January 2020
The Board of Strides Pharma Science at its meeting held on 08 January 2020 has approved the following -Appointment of Dr. R Ananthanarayanan (DIN: 02231540) as Chief Executive Officer & Managing Director of the Company effective 09 January 2020, for a period of 5 years, subject to approval of the Members of the Company. Further, he is also appointed as Key Managerial Personnel of the Company effective 09 January 2020.
2) Re-designation of Arun Kumar (DIN: 00084845) as Executive Director effective 09 January 2020.
Powered by Capital Market - Live News